Literature DB >> 25351289

Incidence and aetiologies of pulmonary granulomatous inflammation: a decade of experience.

Alia Nazarullah1, Robert Nilson, Diego Jose Maselli, Jaishree Jagirdar.   

Abstract

BACKGROUND AND
OBJECTIVE: Granulomatous lung disease (GLD) is caused by a wide range of conditions. Often there is a need to correlate pathological findings with clinical, microbiological or radiological data to determine an aetiology. The aim of this study was to determine the different aetiologies of GLD over the past decade.
METHODS: Among 2228 consecutive lung specimens from 1999 to 2011, 226 cases (10.1%) were positive for GLD. One hundred ninety patients were retrospectively reviewed and diagnoses were assigned based on availability of histological/clinical/microbiological correlation.
RESULTS: A confident, probable and uncertain diagnosis was made in 68.4%, 13.2% and 18.4% patients. The aetiologies comprised infectious, non-infectious and uncertain in 54.7%, 26.8% and 18.4% patients. Mycobacterial infections constituted 27% of all patients, and included atypical, tuberculous and unclassified mycobacteria in order of frequency. Acid-fast bacilli (AFB) were visualized in tissue sections in 29% cases and cultured in 73% cases. Fungal infections comprised 27% of all cases, which included Coccidioides, Cryptococcus, Aspergillus and Histoplasma in order of frequency. Fungi were visualized in tissue sections with Gomori methenamine silver (GMS) stain in 83% patients and cultured in 52% cases. Sarcoidosis was the major non-infectious aetiology, constituting 21% of all patients. Necrosis in granulomas was associated with the presence of infection (P < 0.001).
CONCLUSIONS: The aetiology in necrotizing GLD with negative AFB and GMS stains is most likely infectious due to atypical mycobacteria. Coccidioidomycosis was the most common fungal infection. The aetiology in non-necrotizing GLD is most likely non-infectious, probably sarcoidosis.
© 2014 Asian Pacific Society of Respirology.

Entities:  

Keywords:  coccidiomycosis; granuloma; lung; mycobacteria; sarcoidosis

Mesh:

Year:  2014        PMID: 25351289     DOI: 10.1111/resp.12410

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  7 in total

1.  Sarcoid-like reaction in a patient with uveitis and underlying cancer.

Authors:  Isabel Pascual-Camps; Nieves Alonso-Orcajo; Juan Pablo de la Fuente; Taygan Yilmaz; Miguel Cordero-Coma
Journal:  Int Ophthalmol       Date:  2016-10-19       Impact factor: 2.031

2.  Granulomatous Sarcoidosis Mimics.

Authors:  Marc A Judson
Journal:  Front Med (Lausanne)       Date:  2021-07-08

3.  Etiological profile and main imaging findings in patients with granulomatous diseases who underwent lung biopsy.

Authors:  Camila Vilela de Oliveira; Natally Horvat; Leonardo de Abreu Testagrossa; Davi Dos Santos Romão; Marina Bastos Rassi; Hye Ju Lee
Journal:  Eur J Radiol Open       Date:  2021-01-20

4.  Sarcoidosis with marked necrosis in enlarged lymph nodes mimics mycobacterial infection: a case report.

Authors:  Yosuke Miyashita; Munechika Hara; Shin-Ichiro Iwakami; Hironari Matsuda; Naoko Iwakami; Kazuhisa Takahashi
Journal:  J Med Case Rep       Date:  2021-04-18

5.  Aspergillus Vertebral Osteomyelitis Complicating Pulmonary Granuloma in an Immunocompetent Adult.

Authors:  Yun Li; Yanyi Cen; Yuwen Luo; Zhe Zhu; Shaoxiong Min; Xin Chen
Journal:  Med Princ Pract       Date:  2015-12-14       Impact factor: 1.927

6.  Lung granuloma: A clinicopathologic study of 158 cases.

Authors:  Abdullah Al-Harbi; Salman Al-Otaibi; Abdelmonim Abdulrahman; Fares Al-Jahdali; Fahad Al-Harbi; Hana Bamefleh; Majed Gamdi; Hamdan Al-Jahdali
Journal:  Ann Thorac Med       Date:  2017 Oct-Dec       Impact factor: 2.219

7.  Diagnosis distribution in cases with granulomatous inflammation in lung, pleura, and lymph node biopsies: an experience from a tertiary level single center chest diseases and thoracic surgery hospital.

Authors:  Selma Aydogan Eroglu; Tekin Yildiz; Esin Sonkaya; Murat Kavas; Fatma Ozbaki; Lale Sertçelik; Aycim Sen; Tulin Sevim
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 0.670

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.